Efficacy and Safety of Cipros 10 Association on the Isolated Hypertriglyceridemia and Dyslipidemia Treatment

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 146 participants.

Also called NCT03527069

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 146 participants (enrolled count) (from the registry)
Sponsor
EMS (from the registry)
Registry
  • NCT NCT03527069
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Brazil (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03527069. Randomized; double masking; primary purpose treatment. Start 2021-01-29 (actual); primary completion 2024-08-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Cipros 10 Association on the Isolated Hypertriglyceridemia and Dyslipidemia Treatment
Condition
Hypertriglyceridemia
Condition
Dyslipidemia
Intervention (Drug)
Cipros 10 association
Intervention (Drug)
Crestor 10 mg
Lead sponsor
EMS (class: industry)

Record details

Record id
cardio:ct-nct03527069
Content hash
0f57a632f30c80fb8ab9a5bd913ce0f88154caaed78d837b603c636eaaa18bde